1-20 of 25
Christopher M. Counter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract IA-07: RAS mutation tropism: insight into tumor initation

Christopher M Counter
Journal: Cancer Research
Cancer Res (2024) 84 (17_Supplement_2): IA-07.
https://doi.org/10.1158/1538-7445.PANCREATIC24-IA-07
Published: 15 September 2024
View article titled, Abstract IA-07: RAS mutation tropism: insight into tumor initation
Journal Articles

Abstract 1092: RUNX2 inhibition alters PAX3::FOXO1 driven fusion-positive rhabdomyosarcoma cell state and growth

Elizabeth A. Mendes, Audrey L. Chambers, Samantha J. Weitzel, Michael Deel, Aanandi Munshi, Christopher M. Counter, Seth Zimmerman, John Bushweller, Corinne M. Linardic
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1092.
https://doi.org/10.1158/1538-7445.AM2024-1092
Published: 22 March 2024
View article titled, Abstract 1092: RUNX2 inhibition alters PAX3::FOXO1 driven fusion-positive rhabdomyosarcoma cell state and growth
Journal Articles

Abstract LB263: An in vivo unbiased screen identifies clathrin adaptor protein complex-2 as a novel tumor suppressor

Seth Parker Zimmerman, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): LB263.
https://doi.org/10.1158/1538-7445.AM2023-LB263
Published: 14 April 2023
View article titled, Abstract LB263: An <em>in vivo</em> unbiased screen identifies clathrin adaptor protein complex-2 as a novel tumor suppressor
Journal Articles

Abstract 2579: The tumor landscape is molded by quantitative and qualitative signaling differences between different oncogenic KRAS mutations

Ozgun Le Roux, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2579.
https://doi.org/10.1158/1538-7445.AM2023-2579
Published: 04 April 2023
View article titled, Abstract 2579: The tumor landscape is molded by quantitative and qualitative signaling differences between different oncogenic KRAS mutations
Journal Articles

Abstract 2944: Altering RAS oncogenic activity defines unique oncogenic fates

Ozgun Erdogan, Nicole L. Pershing, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2944.
https://doi.org/10.1158/1538-7445.AM2021-2944
Published: 01 July 2021
View article titled, Abstract 2944: Altering RAS oncogenic activity defines unique oncogenic fates
Journal Articles

Abstract 1085: Interrogating the RAS interactome identifies EFR3A as a novel enhancer of RAS oncogenesis

Hema Adhikari, Walaa Kattan, John F. Hancock, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1085.
https://doi.org/10.1158/1538-7445.AM2020-1085
Published: 15 August 2020
View article titled, Abstract 1085: Interrogating the RAS interactome identifies EFR3A as a novel enhancer of RAS oncogenesis
Journal Articles

Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors

Donita C. Brady, Matthew S. Crowe, Danielle N. Greenberg, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2017) 77 (22): 6240–6252.
https://doi.org/10.1158/0008-5472.CAN-16-1190
Published: 14 November 2017
View article titled, Copper Chelation Inhibits BRAF<sup>V600E</sup>-Driven Melanomagenesis and Counters Resistance to BRAF<sup>V600E</sup> and MEK1/2 Inhibitors
Open the PDF for Copper Chelation Inhibits BRAF<sup>V600E</sup>-Driven Melanomagenesis and Counters Resistance to BRAF<sup>V600E</sup> and MEK1/2 Inhibitors in another window
Includes: Supplementary data
Journal Articles

Abstract IA14: Rare codons capacitate Kras-driven de novo tumorigenesis

Nicole L.K. Pershing, Benjamin L. Lampson, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2017) 77 (6_Supplement): IA14.
https://doi.org/10.1158/1538-7445.Transcontrol16-IA14
Published: 14 March 2017
View article titled, Abstract IA14: Rare codons capacitate Kras-driven de novo tumorigenesis
Journal Articles

Abstract 69: Characterization of an inducible transgenic p53/Kras oncopig model for cancer

Laurie A. Rund, Tiago Collares, Fabiana Seixas, Karine Begnini, Christopher M. Counter, Lawrence B. Schook
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 69.
https://doi.org/10.1158/1538-7445.AM2014-69
Published: 01 October 2014
View article titled, Abstract 69: Characterization of an inducible transgenic p53/Kras oncopig model for cancer
Journal Articles

Abstract 5250: The effect of introducing a C118S mutation into the endogenous Kras gene on early tumorigenesis

Lu Huang, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5250.
https://doi.org/10.1158/1538-7445.AM2014-5250
Published: 01 October 2014
View article titled, Abstract 5250: The effect of introducing a C118S mutation into the endogenous Kras gene on early tumorigenesis
Journal Articles

Abstract 4427: Copper is required for oncogenic BRAF signaling and tumorigenesis

Donita C. Brady, Matthew S. Crowe, Michelle L. Turski, G Aaron Hobbs, Apirat Chaikuad, Stefan Knapp, Sharon L. Campbell, Dennis J. Thiele, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4427.
https://doi.org/10.1158/1538-7445.AM2014-4427
Published: 01 October 2014
View article titled, Abstract 4427: Copper is required for oncogenic BRAF signaling and tumorigenesis
Journal Articles

Abstract 4426: Tumor suppressive effects of wild-type Hras on oncogenic Kras-driven pancreatic tumorigenesis

Jamie D. Weyandt, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4426.
https://doi.org/10.1158/1538-7445.AM2014-4426
Published: 01 October 2014
View article titled, Abstract 4426: Tumor suppressive effects of wild-type Hras on oncogenic Kras-driven pancreatic tumorigenesis
Journal Articles

Abstract 4447: Generation of a conditional S194A mutant RalA allele in mice

Matthew S. Crowe, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4447.
https://doi.org/10.1158/1538-7445.AM2014-4447
Published: 01 October 2014
View article titled, Abstract 4447: Generation of a conditional S194A mutant RalA allele in mice
Journal Articles

Abstract 4294: Copper is required for oncogenic BRAF signaling and tumorigenesis.

Donita C. Brady, Matthew S. Crowe, Michelle L. Turski, Dennis J. Thiele, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4294.
https://doi.org/10.1158/1538-7445.AM2013-4294
Published: 15 April 2013
View article titled, Abstract 4294: Copper is required for oncogenic BRAF signaling and tumorigenesis.
Journal Articles

Targeting eNOS in Pancreatic Cancer

Benjamin L. Lampson, S. DiSean Kendall, Brooke B. Ancrile, Meghan M. Morrison, Michael J. Shealy, Katharine S. Barrientos, Matthew S. Crowe, David F. Kashatus, Rebekah R. White, Susan B. Gurley, Diana M. Cardona, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2012) 72 (17): 4472–4482.
https://doi.org/10.1158/0008-5472.CAN-12-0057
Published: 30 August 2012
View article titled, Targeting eNOS in Pancreatic Cancer
Open the PDF for Targeting eNOS in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 2584: eNOS as a therapeutic target in pancreatic cancer

Katharine S. Barrientos, Benjamin L. Lampson, Stephan D. Kendall, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2584.
https://doi.org/10.1158/1538-7445.AM2011-2584
Published: 15 April 2011
View article titled, Abstract 2584: eNOS as a therapeutic target in pancreatic cancer
Journal Articles

Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma

Sarasija Naini, Katherine T. Etheridge, Stacey J. Adam, Stephen J. Qualman, Rex C. Bentley, Christopher M. Counter, Corinne M. Linardic
Journal: Cancer Research
Cancer Res (2008) 68 (23): 9583–9588.
https://doi.org/10.1158/0008-5472.CAN-07-6178
Published: 01 December 2008
View article titled, Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma
Open the PDF for Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma in another window
Includes: Supplementary data
Journal Articles

The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis

Yi-Shan Lee, Kian-Huat Lim, Xing Guo, Yoshiharu Kawaguchi, Yasheng Gao, Tomasa Barrientos, Peter Ordentlich, Xiao-Fan Wang, Christopher M. Counter, Tso-Pang Yao
Journal: Cancer Research
Cancer Res (2008) 68 (18): 7561–7569.
https://doi.org/10.1158/0008-5472.CAN-08-0188
Published: 14 September 2008
View article titled, The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis
Open the PDF for The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis in another window
Includes: Supplementary data
Journal Articles

The PAX3-FKHR Fusion Gene of Rhabdomyosarcoma Cooperates with Loss of p16INK4A to Promote Bypass of Cellular Senescence

Corinne M. Linardic, Sarasija Naini, James E. Herndon, II, Chimen Kesserwan, Stephen J. Qualman, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2007) 67 (14): 6691–6699.
https://doi.org/10.1158/0008-5472.CAN-06-3210
Published: 17 July 2007
View article titled, The <em>PAX3-FKHR</em> Fusion Gene of Rhabdomyosarcoma Cooperates with Loss of p16<sup>INK4A</sup> to Promote Bypass of Cellular Senescence
Open the PDF for The <em>PAX3-FKHR</em> Fusion Gene of Rhabdomyosarcoma Cooperates with Loss of p16<sup>INK4A</sup> to Promote Bypass of Cellular Senescence in another window
Journal Articles

A porcine model of tumorigenesis

Stacey J. Adam, Laurie A. Rund, Kristy N. Kuzmuk, Lawrence B. Schook, Christopher M. Counter
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 65.
Published: 15 April 2006
View article titled, A porcine model of tumorigenesis